Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial

BACKGROUND: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organization (WHO) for HIV-1-infected individuals in settings with high infectious disease prevalence. The WHO 2006 guidelines were developed prior to the scale-up of antiretroviral therapy (ART). The threshold for CTX di...

Descripción completa

Detalles Bibliográficos
Autores principales: Polyak, Christina S., Yuhas, Krista, Singa, Benson, Khaemba, Monica, Walson, Judd, Richardson, Barbra A., John-Stewart, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701407/
https://www.ncbi.nlm.nih.gov/pubmed/26731191
http://dx.doi.org/10.1371/journal.pmed.1001934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701407/
https://www.ncbi.nlm.nih.gov/pubmed/26731191
http://dx.doi.org/10.1371/journal.pmed.1001934

Ejemplares similares